IP Library Granted Patent US 12,548,079
Granted Patent B2
US 12,548,079 · App. 18/098,150 · Granted Feb 10, 2026

Systems and methods for determining and communicating patient incentive information to a prescriber

Inventor: Roger G. Pinsonneault (Alpharetta, GA)
Assignee: McKesson Corporation
G06Q40/08G06Q10/10G16H20/10G16H40/20G16H10/60
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,548,079
App. No.
18/098,150
Granted
Feb 10, 2026
Kind
B2
Abstract

Systems and methods are provided for determining and communicating patient incentive information to a prescriber. The patient incentive information may adjust the patient copay amount for a prescribed medication. The patient incentive information may be determined by evaluating pharmacy identification information and medication identifiers in a received prescription benefit check transaction and/or adjudicated response to a healthcare transaction to determine if an incentive is available to be applied to the current transaction. The incentive amount may be retrieved and the patient copay amount in the adjudicated response may be amended prior to transmitting the adjudicated response to the prescriber of the medication.

Claims (56)

1 . A computer-implemented method, comprising:

receiving, from a prescriber computer, a prescription benefit check transaction;

in response to, and in real-time or near real-time relative to receiving the prescription benefit check transaction, reformatting, by one or more service provider computers, the prescription benefit check transaction to generate a prescriber billing request transaction, in a National Council for Prescription Drug Programs (NCPDP) format, and associated with a prescription benefit plan and a first claims processor computer, wherein reformatting the prescription benefit check transaction to generate a prescriber billing request transaction in a National Council for Prescription Drug Programs (NCPDP) format, comprises:

populating the prescriber billing request transaction with a medication identifier identifying a medication to be prescribed and a patient identifier identifying a patient to receive the prescribed medication from the prescription benefit check transaction;

populating the prescriber billing request transaction with a pharmacy identifier; and

inserting, by the one or more service provider computers, the pharmacy identifier into the prescriber billing request transaction;

further in response to, and in real-time or near real-time relative to receiving the prescription benefit check transaction, generating an eligibility inquiry transaction in an X12 270 format, different than a format of the prescription benefit check transaction and the NCPDP format, wherein the eligibility inquiry transaction is associated with a health insurance company and a second claims processor computer, wherein generating the eligibility inquiry transaction, in the X12 270 format comprises:

populating the eligibility inquiry transaction with a medication identifier identifying a medication to be prescribed and a patient identifier identifying a patient to receive the prescribed medication from the prescription benefit check transaction; and

populating the eligibility inquiry transaction with a pharmacy identifier; and

transmitting the prescriber billing request transaction to the first claims processor computer;

transmitting the eligibility inquiry transaction to the second claims processor computer;

receiving adjudicated responses from the first claims processor computer and the second claims processor computer;

in response to receiving the adjudicated responses, determining, by the one or more service provider computers, an incentive amount to apply to a first patient copay amount determined from the adjudicated responses;

generating, by the one or more service provider computers, a second patient copay amount by reducing the first patient copay amount based upon the incentive amount;

generating a prescription benefit check response, in a format different than the prescription benefit check transaction, wherein the prescription benefit check response comprises a transaction type, a transaction status indicator, the second patient copay amount, and a claims processor computer message; and

transmitting, by the one or more service provider computers, the prescription benefit check response to the prescriber computer in real-time or near real-time relative to receiving the prescription benefit check transaction.

2 . The computer-implemented method of claim 1 , further comprising:

transmitting, by the one or more service provider computers to the prescriber computer, an incentive notification message indicating the incentive amount and a provider of the incentive amount.

3 . The computer-implemented method of claim 1 , wherein the prescription benefit check response is transmitted in real-time or near real-time to the prescription benefit check response to a prescriber computer responsive to receiving the prescription benefit check transaction.

4 . An apparatus comprising at least one processor and at least one memory including computer program code, the at least one memory and the computer program code configured to, with the processor, cause the apparatus to at least:

receive, from a prescriber computer, a prescription benefit check transaction;

in response to, and in real-time or near real-time relative to receiving the prescription benefit check transaction, reformat, by one or more service provider computers, the prescription benefit check transaction to generate a prescriber billing request transaction, in a National Council for Prescription Drug Programs (NCPDP) format, and associated with a prescription benefit plan and a first claims processor computer wherein reformatting the prescription benefit check transaction to generate a prescriber billing request transaction in a National Council for Prescription Drug Programs (NCPDP) format, comprises:

populating the prescriber billing request transaction with a medication identifier identifying a medication to be prescribed and a patient identifier identifying a patient to receive the prescribed medication from the prescription benefit check transaction;

populating the prescriber billing request transaction with a pharmacy identifier; and

inserting, by the one or more service provider computers, the pharmacy identifier into the prescriber billing request transaction;

further in response to, and in real-time or near real-time relative to receiving the prescription benefit check transaction, generate an eligibility inquiry transaction in an X12 270 format, different than a format of the prescription benefit check transaction and the NCPDP format, wherein the eligibility inquiry transaction is associated with a health insurance company and a second claims processor computer, wherein generating the eligibility inquiry transaction, in the X12 270 format comprises:

populating the eligibility inquiry transaction with a medication identifier identifying a medication to be prescribed and a patient identifier identifying a patient to receive the prescribed medication from the prescription benefit check transaction;

populating the eligibility inquiry transaction with a pharmacy identifier; and

transmitting the prescriber billing request transaction to the first claims processor computer;

transmit the eligibility inquiry transaction to the second claims processor computer;

receive adjudicated responses from the first claims processor computer and the second claims processor computer;

in response to receiving the adjudicated response, determine, by the one or more service provider computers, an incentive amount to apply to a first patient copay amount determined from the adjudicated responses;

generate, by the one or more service provider computers, a second patient copay amount by reducing the first patient copay amount based upon the incentive amount;

generate a prescription benefit check response, in a format different than the prescription benefit check transaction, wherein the prescription benefit check response comprises a transaction type, a transaction status indicator, the second patient copay amount, and a claims processor computer message; and

transmit, by the one or more service provider computers, the prescription benefit check response to the prescriber computer in real-time or near real-time relative to receiving the prescription benefit check transaction.

5 . The apparatus of claim 4 , wherein the at least one memory and the computer program code are further configured to cause the apparatus to at least:

transmit, by the one or more service provider computers to the prescriber computer, an incentive notification message indicating the incentive amount and a provider of the incentive amount.

6 . The apparatus of claim 4 , wherein the prescription benefit check response is transmitted in real-time or near real-time to the prescription benefit check response to a prescriber computer responsive to receiving the prescription benefit check transaction.

7 . A computer program product comprising at least one non-transitory computer-readable storage medium having computer-executable program code instructions stored therein, the computer-executable program code instructions comprising program code instructions to:

receive, from a prescriber computer, a prescription benefit check transaction;

in response to, and in real-time or near real-time relative to receiving the prescription benefit check transaction, reformat, by one or more service provider computers, the prescription benefit check transaction to generate a prescriber billing request transaction, in a National Council for Prescription Drug Programs (NCPDP) format, and associated with a prescription benefit plan and a first claims processor computer, wherein reformatting the prescription benefit check transaction to generate a prescriber billing request transaction in a National Council for Prescription Drug Programs (NCPDP) format, comprises:

populate the prescriber billing request transaction with a medication identifier identifying a medication to be prescribed and a patient identifier identifying a patient to receive the prescribed medication from the prescription benefit check transaction;

populate the prescriber billing request transaction with a pharmacy identifier; and

insert, by the one or more service provider computers, the pharmacy identifier into the prescriber billing request transaction;

further in response to, and in real-time or near real-time relative to receiving the prescription benefit check transaction, generate an eligibility inquiry transaction in an X12 270 format, different than a format of the prescription benefit check transaction and the NCPDP format, wherein the eligibility inquiry transaction is associated with a health insurance company and a second claims processor computer, wherein generating the eligibility inquiry transaction, in the X12 270 format comprises:

populating the eligibility inquiry transaction with a medication identifier identifying a medication to be prescribed and a patient identifier identifying a patient to receive the prescribed medication from the prescription benefit check transaction;

populating the eligibility inquiry transaction with a pharmacy identifier; and

transmitting the prescriber billing request transaction to the first claims processor computer;

transmit the eligibility inquiry transaction to the second claims processor computer;

receive adjudicated responses from the first claims processor computer and the second claims processor computer;

in response to receiving the adjudicated responses, determine, by the one or more service provider computers, an incentive amount to apply to a first patient copay amount determined from the adjudicated responses;

generate, by the one or more service provider computers, a second patient copay amount by reducing the first patient copay amount based upon the incentive amount;

generate a prescription benefit check response, in a format different than the prescription benefit check transaction, wherein the prescription benefit check response comprises a transaction type, a transaction status indicator, the second patient copay amount, and a claims processor computer message; and

transmit, by the one or more service provider computers, the prescription benefit check response to the prescriber computer in real-time or near real-time relative to receiving the prescription benefit check transaction.

8 . The computer program product of claim 7 , wherein the computer-executable program code instructions further comprise program code instructions to:

transmit, by the one or more service provider computers to the prescriber computer, an incentive notification message indicating the incentive amount and a provider of the incentive amount.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 20, 2023
From: PINSONNEAULT, ROGER G.
To: MCKESSON FINANCIAL HOLDINGS
Reel/Frame 062430/0099 →
CHANGE OF NAME Recorded Jan 20, 2023
From: MCKESSON FINANCIAL HOLDINGS
To: MCKESSON FINANCIAL HOLDINGS UNLIMITED COMPANY
Reel/Frame 062430/0109 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 20, 2023
From: MCKESSON FINANCIAL HOLDINGS UNLIMITED COMPANY
To: MCKESSON CORPORATION
Reel/Frame 062439/0338 →
Continuity (3)
Continuation 16552021 · Aug 27, 2019
Continuation 14181011 · Feb 14, 2014
Related Publication 20230153914A1 · May 18, 2023
References Cited (400)
US 5012035A · Sartori et al. · 1991 [cited by applicant]
US 5173851A · Off et al. · 1992 [cited by applicant]
US 5595342A · McNair et al. · 1997 [cited by applicant]
US 5628530A · Thornton · 1997 [cited by applicant]
US 5726092A · Mathews et al. · 1998 [cited by applicant]
US 5757898A · Nishikawa · 1998 [cited by applicant]
US 5769228A · Wroblewski · 1998 [cited by applicant]
US 6012035A · Freeman et al. · 2000 [cited by applicant]
US 6111218A · Akers et al. · 2000 [cited by applicant]
US 6463462B1 · Smith et al. · 2002 [cited by applicant]
US 6595342B1 · Maritzen et al. · 2003 [cited by applicant]
US 6726092B2 · Goldberg et al. · 2004 [cited by applicant]
US 6757898B1 · Ilsen et al. · 2004 [cited by applicant]
US 6769228B1 · Mahar · 2004 [cited by applicant]
US 7155397B2 · Alexander et al. · 2006 [cited by applicant]
US 7192741B2 · Otte et al. · 2007 [cited by applicant]
US 7337129B1 · Lowry et al. · 2008 [cited by applicant]
US 7346768B2 · DiRienzo · 2008 [cited by applicant]
US 7409632B1 · DiRienzo · 2008 [cited by applicant]
US 7426476B2 · Munoz et al. · 2008 [cited by applicant]
US 7734483B1 · Smith et al. · 2010 [cited by applicant]
US 7783383B2 · Eliuk et al. · 2010 [cited by applicant]
US 7840424B2 · Wiley et al. · 2010 [cited by applicant]
US 7856364B1 · Wiley et al. · 2010 [cited by applicant]
US 7912741B1 · Pinsonneault · 2011 [cited by applicant]
US 7921021B1 · Newman · 2011 [cited by applicant]
US 8036913B1 · Pinsonneault · 2011 [cited by examiner]
US 8036914B1 · Pinsonneault · 2011 [cited by applicant]
US 8036918B1 · Pinsonneault · 2011 [cited by applicant]
US 8050943B1 · Wiley et al. · 2011 [cited by applicant]
US 8060379B1 · Pinsonneault et al. · 2011 [cited by applicant]
US 8126743B1 · Wilk · 2012 [cited by applicant]
US 8326773B1 · Bellamy · 2012 [cited by applicant]
US 8346571B2 · Kalies, Jr. · 2013 [cited by applicant]
US 8412537B1 · Fenton et al. · 2013 [cited by applicant]
US 8442847B1 · Shrivastava · 2013 [cited by applicant]
US 8489415B1 · Ringold · 2013 [cited by applicant]
US 8521557B1 · Ringold et al. · 2013 [cited by applicant]
US 8560340B1 · Ringold · 2013 [cited by applicant]
US 8639523B1 · Pinsonneault · 2014 [cited by applicant]
US 8645162B2 · Boerger et al. · 2014 [cited by applicant]
US 8671018B2 · Thomas et al. · 2014 [cited by applicant]
US 8712797B1 · Bezdek et al. · 2014 [cited by applicant]
US 8738399B1 · Abou Nader et al. · 2014 [cited by applicant]
US 8786650B1 · Eller et al. · 2014 [cited by applicant]
US 8799018B1 · Rea et al. · 2014 [cited by applicant]
US 8984059B2 · Johnson · 2015 [cited by applicant]
US 9026507B2 · Shraim et al. · 2015 [cited by applicant]
US 9100793B2 · Johnson · 2015 [cited by applicant]
US 9171322B2 · Spievak et al. · 2015 [cited by applicant]
US 9356947B2 · Shraim et al. · 2016 [cited by applicant]
US 9760871B1 · Pourfallah et al. · 2017 [cited by applicant]
US 9779129B1 · Lequeux · 2017 [cited by applicant]
US 9786023B2 · Cohan et al. · 2017 [cited by applicant]
US 10109027B1 · Stack · 2018 [cited by applicant]
US 10157262B1 · Pinsonneault · 2018 [cited by applicant]
US 10262383B1 · Harris, Sr. et al. · 2019 [cited by applicant]
US 10331855B1 · Bratton et al. · 2019 [cited by applicant]
US 10417380B1 · Kaye et al. · 2019 [cited by applicant]
US 10489552B2 · Pinsonneault · 2019 [cited by applicant]
US 10496793B1 · Lawrence et al. · 2019 [cited by applicant]
US 10565656B1 · Pinsonneault et al. · 2020 [cited by applicant]
US 10606984B1 · Kaye et al. · 2020 [cited by applicant]
US 10616146B1 · Hopkins et al. · 2020 [cited by applicant]
US 10628797B2 · Shraim et al. · 2020 [cited by applicant]
US 10642812B1 · Hopkins et al. · 2020 [cited by applicant]
US 10713694B1 · Harris et al. · 2020 [cited by applicant]
US 10747848B2 · Guinan · 2020 [cited by applicant]
US 10778618B2 · Karnin et al. · 2020 [cited by applicant]
US 10862832B1 · Harris · 2020 [cited by applicant]
US 10924545B2 · Momchilov et al. · 2021 [cited by applicant]
US 10924585B1 · Harris et al. · 2021 [cited by applicant]
US 10929932B1 · Golden et al. · 2021 [cited by applicant]
US 10978198B1 · Pinsonneault · 2021 [cited by applicant]
US 10999224B1 · Frechen et al. · 2021 [cited by applicant]
US 11043293B1 · Salzbrenner · 2021 [cited by applicant]
US 11170394B1 · Macinski · 2021 [cited by applicant]
US 11398992B1 · Frechen et al. · 2022 [cited by applicant]
US 11418468B1 · Harris · 2022 [cited by applicant]
US 11443835B1 · Gangaikondan-Iyer et al. · 2022 [cited by applicant]
US 11508471B1 · Anselmi et al. · 2022 [cited by applicant]
US 11514137B1 · Kaye et al. · 2022 [cited by applicant]
US 11562437B1 · Hopkins et al. · 2023 [cited by applicant]
US 11587657B2 · Hopkins et al. · 2023 [cited by applicant]
US 11640618B1 · Burdine · 2023 [cited by applicant]
US 20010029483A1 · Schultz et al. · 2001 [cited by applicant]
US 20010034613A1 · Rubsamen · 2001 [cited by applicant]
US 20010037216A1 · Oscar et al. · 2001 [cited by applicant]
US 20010039589A1 · Aho et al. · 2001 [cited by applicant]
US 20010056359A1 · Abreu · 2001 [cited by applicant]
US 20020002495A1 · Ullman · 2002 [cited by applicant]
US 20020004812A1 · Motoyama · 2002 [cited by applicant]
US 20020032582A1 · Feeney et al. · 2002 [cited by applicant]
US 20020032583A1 · Joao · 2002 [cited by applicant]
US 20020035484A1 · McCormick · 2002 [cited by applicant]
US 20020087583A1 · Morgan et al. · 2002 [cited by applicant]
US 20020111832A1 · Judge · 2002 [cited by applicant]
US 20020133379A1 · Lewis et al. · 2002 [cited by applicant]
US 20020143579A1 · Docherty et al. · 2002 [cited by applicant]
US 20020147614A1 · Doerr et al. · 2002 [cited by applicant]
US 20020188552A1 · Kavounas et al. · 2002 [cited by applicant]
US 20020198831A1 · Patricelli et al. · 2002 [cited by applicant]
US 20030009367A1 · Morrison · 2003 [cited by applicant]
US 20030050796A1 · Baldwin · 2003 [cited by applicant]
US 20030050799A1 · Jay et al. · 2003 [cited by applicant]
US 20030069760A1 · Gelber · 2003 [cited by applicant]
US 20030074234A1 · Stasny · 2003 [cited by applicant]
US 20030097310A1 · Ono et al. · 2003 [cited by applicant]
US 20030130875A1 · Hawash et al. · 2003 [cited by applicant]
US 20030149625A1 · Leonardi et al. · 2003 [cited by applicant]
US 20030154163A1 · Phillips et al. · 2003 [cited by applicant]
US 20030172008A1 · Hage et al. · 2003 [cited by applicant]
US 20030187690A1 · Miller · 2003 [cited by applicant]
US 20030229540A1 · Algiene · 2003 [cited by applicant]
US 20030236747A1 · Sager · 2003 [cited by applicant]
US 20040006490A1 · Gingrich et al. · 2004 [cited by applicant]
US 20040039599A1 · Fralic · 2004 [cited by applicant]
US 20040054685A1 · Rahn et al. · 2004 [cited by applicant]
US 20040059607A1 · Ball et al. · 2004 [cited by applicant]
US 20040073456A1 · Gottlieb et al. · 2004 [cited by applicant]
US 20040073457A1 · Kalies · 2004 [cited by applicant]
US 20040078222A1 · Khan et al. · 2004 [cited by applicant]
US 20040078234A1 · Tallal, Jr. · 2004 [cited by applicant]
US 20040088187A1 · Chudy et al. · 2004 [cited by applicant]
US 20040103062A1 · Wood et al. · 2004 [cited by applicant]
US 20040117323A1 · Mindala · 2004 [cited by applicant]
US 20040148198A1 · Kalies · 2004 [cited by applicant]
US 20040153336A1 · Virdee et al. · 2004 [cited by applicant]
US 20040199545A1 · Wagner et al. · 2004 [cited by applicant]
US 20040236630A1 · Kost et al. · 2004 [cited by applicant]
US 20040249745A1 · Baaren · 2004 [cited by applicant]
US 20050015280A1 · Gabel et al. · 2005 [cited by applicant]
US 20050060201A1 · Connely, III et al. · 2005 [cited by applicant]
US 20050065821A1 · Kalies, Jr. · 2005 [cited by applicant]
US 20050075932A1 · Mankoff · 2005 [cited by applicant]
US 20050080692A1 · Padam et al. · 2005 [cited by applicant]
US 20050102169A1 · Wilson · 2005 [cited by applicant]
US 20050154627A1 · Zuzek et al. · 2005 [cited by applicant]
US 20050187793A1 · Myles · 2005 [cited by applicant]
US 20050197862A1 · Paterson et al. · 2005 [cited by applicant]
US 20050240442A1 · Lapsker et al. · 2005 [cited by applicant]
US 20050240473A1 · Ayers et al. · 2005 [cited by applicant]
US 20050261939A1 · Augspurger et al. · 2005 [cited by applicant]
US 20050288972A1 · Marvin et al. · 2005 [cited by applicant]
US 20060020514A1 · Yered · 2006 [cited by applicant]
US 20060026041A1 · Ullman · 2006 [cited by applicant]
US 20060036470A1 · Oaks · 2006 [cited by applicant]
US 20060085231A1 · Brofman · 2006 [cited by applicant]
US 20060085385A1 · Foster et al. · 2006 [cited by applicant]
US 20060113376A1 · Reed et al. · 2006 [cited by applicant]
US 20060149595A1 · Williams et al. · 2006 [cited by applicant]
US 20060149784A1 · Tholl et al. · 2006 [cited by applicant]
US 20060155578A1 · Eisenberger et al. · 2006 [cited by applicant]
US 20060184391A1 · Barre et al. · 2006 [cited by applicant]
US 20060212318A1 · Dooley · 2006 [cited by applicant]
US 20060212345A1 · Soza et al. · 2006 [cited by applicant]
US 20060224414A1 · Astrup et al. · 2006 [cited by applicant]
US 20060224417A1 · Werner · 2006 [cited by applicant]
US 20060224443A1 · Soza et al. · 2006 [cited by applicant]
US 20060235747A1 · Hammond et al. · 2006 [cited by applicant]
US 20060259363A1 · Jhetam et al. · 2006 [cited by applicant]
US 20070005402A1 · Kennedy et al. · 2007 [cited by applicant]
US 20070033137A1 · Provost et al. · 2007 [cited by applicant]
US 20070043589A1 · Warren et al. · 2007 [cited by applicant]
US 20070043595A1 · Pederson · 2007 [cited by applicant]
US 20070050209A1 · Yered · 2007 [cited by applicant]
US 20070050210A1 · Wiley, II · 2007 [cited by applicant]
US 20070067186A1 · Brenner et al. · 2007 [cited by applicant]
US 20070094133A1 · Anandarao et al. · 2007 [cited by applicant]
US 20070108053A1 · Cramer et al. · 2007 [cited by applicant]
US 20070136100A1 · Daugherty et al. · 2007 [cited by applicant]
US 20070162303A1 · Wiley et al. · 2007 [cited by applicant]
US 20070168228A1 · Lawless · 2007 [cited by applicant]
US 20070185799A1 · Harrison et al. · 2007 [cited by applicant]
US 20070191985A1 · Bain · 2007 [cited by applicant]
US 20070194352A1 · Han · 2007 [cited by applicant]
US 20070202886A1 · Dhebri et al. · 2007 [cited by applicant]
US 20070204043A1 · Espinosa et al. · 2007 [cited by applicant]
US 20070219813A1 · Moore · 2007 [cited by applicant]
US 20070233525A1 · Boyle · 2007 [cited by applicant]
US 20070233526A1 · Hoffman et al. · 2007 [cited by applicant]
US 20070239493A1 · Sweetland et al. · 2007 [cited by applicant]
US 20070250341A1 · Howe et al. · 2007 [cited by applicant]
US 20070260750A1 · Feied et al. · 2007 [cited by applicant]
US 20070276697A1 · Wiley et al. · 2007 [cited by applicant]
US 20070294765A1 · Rihn et al. · 2007 [cited by applicant]
US 20070299915A1 · Shraim et al. · 2007 [cited by applicant]
US 20080033750A1 · Burriss · 2008 [cited by examiner]
US 20080103836A1 · Park et al. · 2008 [cited by applicant]
US 20080112411A1 · Stafford et al. · 2008 [cited by applicant]
US 20080152107A1 · Mendiola · 2008 [cited by applicant]
US 20080183492A1 · Warren et al. · 2008 [cited by applicant]
US 20080215361A1 · Nunnari et al. · 2008 [cited by applicant]
US 20080262948A1 · Grady et al. · 2008 [cited by applicant]
US 20090006141A1 · Karr · 2009 [cited by applicant]
US 20090030719A1 · Nadas et al. · 2009 [cited by applicant]
US 20090064330A1 · Shraim et al. · 2009 [cited by applicant]
US 20090083064A1 · Mahinda · 2009 [cited by applicant]
US 20090094051A1 · Ard et al. · 2009 [cited by applicant]
US 20090100099A1 · Buckwalter · 2009 [cited by applicant]
US 20090106313A1 · Boldyga · 2009 [cited by applicant]
US 20090112707A1 · Weiss et al. · 2009 [cited by applicant]
US 20090198510A1 · Ditto · 2009 [cited by applicant]
US 20090204477A1 · Urso · 2009 [cited by applicant]
US 20090287558A1 · Seth et al. · 2009 [cited by applicant]
US 20090313112A1 · Champ et al. · 2009 [cited by applicant]
US 20090327363A1 · Cullen et al. · 2009 [cited by applicant]
US 20100030667A1 · Chudy et al. · 2010 [cited by applicant]
US 20100057640A1 · Cannata · 2010 [cited by applicant]
US 20100070298A1 · Kalies · 2010 [cited by applicant]
US 20100144259A1 · Allexon et al. · 2010 [cited by applicant]
US 20100145730A1 · Abreu · 2010 [cited by applicant]
US 20100161353A1 · Mayaud · 2010 [cited by applicant]
US 20100217622A1 · Brown et al. · 2010 [cited by applicant]
US 20100249045A1 · Babul · 2010 [cited by applicant]
US 20100285821A1 · Smeeding et al. · 2010 [cited by applicant]
US 20100287001A1 · Pearce et al. · 2010 [cited by applicant]
US 20100293236A1 · Wisner et al. · 2010 [cited by applicant]
US 20110015978A1 · Welch, Jr. · 2011 [cited by examiner]
US 20110112871A1 · Simonowski et al. · 2011 [cited by applicant]
US 20110161109A1 · Pinsonneault et al. · 2011 [cited by applicant]
US 20110196697A1 · Akers · 2011 [cited by applicant]
US 20110288886A1 · Whiddon et al. · 2011 [cited by applicant]
US 20110288925A1 · Thomas et al. · 2011 [cited by applicant]
US 20120053958A1 · Marshall et al. · 2012 [cited by applicant]
US 20120109839A1 · Anderson et al. · 2012 [cited by applicant]
US 20120136809A1 · Cannata et al. · 2012 [cited by applicant]
US 20120143627A1 · Ruben et al. · 2012 [cited by applicant]
US 20120166268A1 · Griffiths · 2012 [cited by applicant]
US 20120179481A1 · Patel et al. · 2012 [cited by applicant]
US 20120185263A1 · Emert · 2012 [cited by applicant]
US 20120185264A1 · Demogenes et al. · 2012 [cited by applicant]
US 20120253829A1 · John et al. · 2012 [cited by applicant]
US 20120253830A1 · John et al. · 2012 [cited by applicant]
US 20120253831A1 · John et al. · 2012 [cited by applicant]
US 20120253832A1 · John et al. · 2012 [cited by applicant]
US 20120253833A1 · John et al. · 2012 [cited by applicant]
US 20120253846A1 · John et al. · 2012 [cited by applicant]
US 20120265591A1 · Hwang · 2012 [cited by applicant]
US 20120303382A1 · Paul et al. · 2012 [cited by applicant]
US 20120323608A1 · Herzlinger · 2012 [cited by applicant]
US 20130041968A1 · Cohen et al. · 2013 [cited by applicant]
US 20130046610A1 · Abraham · 2013 [cited by applicant]
US 20130103602A1 · Melnick et al. · 2013 [cited by applicant]
US 20130144715A1 · Kranzley et al. · 2013 [cited by applicant]
US 20130179180A1 · Patra · 2013 [cited by applicant]
US 20130191147A1 · Harrell · 2013 [cited by applicant]
US 20130197980A1 · Lerner et al. · 2013 [cited by applicant]
US 20130246082A1 · Brylawski et al. · 2013 [cited by applicant]
US 20130311389A1 · Kaehler et al. · 2013 [cited by applicant]
US 20140039911A1 · Iyer · 2014 [cited by applicant]
US 20140088985A1 · Grant et al. · 2014 [cited by applicant]
US 20140214435A1 · Previdi · 2014 [cited by applicant]
US 20140249861A1 · Gamble et al. · 2014 [cited by applicant]
US 20140249864A1 · Sultan et al. · 2014 [cited by applicant]
US 20140278448A1 · Sadeghi et al. · 2014 [cited by applicant]
US 20140278456A1 · Milosevich et al. · 2014 [cited by applicant]
US 20140278531A1 · Gupta · 2014 [cited by applicant]
US 20150032465A1 · Sundar et al. · 2015 [cited by applicant]
US 20150088557A1 · Huynh et al. · 2015 [cited by applicant]
US 20150142479A1 · Porter et al. · 2015 [cited by applicant]
US 20150149197A1 · Guinan · 2015 [cited by examiner]
US 20150154565A1 · Kaehler et al. · 2015 [cited by applicant]
US 20150154588A1 · Purves et al. · 2015 [cited by applicant]
US 20150195224A1 · Karnin et al. · 2015 [cited by applicant]
US 20150213195A1 · Blechman · 2015 [cited by applicant]
US 20150234991A1 · Pinsonneault · 2015 [cited by applicant]
US 20150235177A1 · Shraim et al. · 2015 [cited by applicant]
US 20150269695A1 · Pinsonneault et al. · 2015 [cited by applicant]
US 20150278472A1 · King · 2015 [cited by applicant]
US 20150332422A1 · Gilmartin · 2015 [cited by applicant]
US 20150356255A1 · Simpson et al. · 2015 [cited by applicant]
US 20150371000A1 · Pinsonneault · 2015 [cited by applicant]
US 20160012465A1 · Sharp · 2016 [cited by applicant]
US 20160103978A1 · Stong · 2016 [cited by applicant]
US 20160140593A1 · Smeeding et al. · 2016 [cited by applicant]
US 20160213512A1 · Palanker et al. · 2016 [cited by applicant]
US 20160267544A1 · Flood et al. · 2016 [cited by applicant]
US 20160267545A1 · Glass et al. · 2016 [cited by applicant]
US 20160307195A1 · Cantwell et al. · 2016 [cited by applicant]
US 20160321406A1 · Timmerman et al. · 2016 [cited by applicant]
US 20160321410A1 · Timmerman et al. · 2016 [cited by applicant]
US 20160358142A1 · Hillen · 2016 [cited by applicant]
US 20160358293A1 · Berger et al. · 2016 [cited by applicant]
US 20160359795A1 · Fehling · 2016 [cited by applicant]
US 20170034087A1 · Borenstein et al. · 2017 [cited by applicant]
US 20170039331A1 · Bezdek et al. · 2017 [cited by applicant]
US 20170220768A1 · Tanner, Jr. et al. · 2017 [cited by applicant]
US 20170255759A1 · McGrath · 2017 [cited by applicant]
US 20170323295A1 · Kranzley et al. · 2017 [cited by applicant]
US 20170324695A1 · Fischer et al. · 2017 [cited by applicant]
US 20170329922A1 · Eberting et al. · 2017 [cited by applicant]
US 20180012244A1 · Leonardi · 2018 [cited by applicant]
US 20180075212A1 · Kubey · 2018 [cited by applicant]
US 20180075215A1 · Loiacono · 2018 [cited by applicant]
US 20180366810A1 · Nero et al. · 2018 [cited by applicant]
US 20190095582A1 · Waits · 2019 [cited by applicant]
US 20190213212A1 · Adato et al. · 2019 [cited by applicant]
US 20190252049A1 · Fotsch et al. · 2019 [cited by applicant]
US 20190348160A1 · Heavelyn · 2019 [cited by applicant]
US 20190371444A1 · Glass et al. · 2019 [cited by applicant]
US 20190385733A1 · Kaye et al. · 2019 [cited by applicant]
US 20190385734A1 · Pinsonneault · 2019 [cited by applicant]
US 20200105392A1 · Karkazis et al. · 2020 [cited by applicant]
US 20200143946A1 · Lewis · 2020 [cited by applicant]
US 20200242626A1 · Agarwal · 2020 [cited by applicant]
US 20200372988A1 · Bezdek et al. · 2020 [cited by applicant]
US 20200395114A1 · Bachwani · 2020 [cited by applicant]
US 20210217044A1 · Sigsbee · 2021 [cited by applicant]
US 20210287774A1 · Curtiss et al. · 2021 [cited by applicant]
US 20210319887A1 · Derrick, Jr. et al. · 2021 [cited by applicant]
US 20210374872A1 · Stewart et al. · 2021 [cited by applicant]
US 20210374876A1 · Cedergreen · 2021 [cited by applicant]
US 20210407642A1 · Xia et al. · 2021 [cited by applicant]
AU 2003243327A · 2003 [cited by applicant]
CA 2482370A1 · 2006 [cited by applicant]
CA 2792252A1 · 2013 [cited by applicant]
CA 2810686A1 · 2013 [cited by applicant]
CN 102362778 · 2012 [cited by applicant]
KR 100755440 · 2007 [cited by applicant]
KR 100793852 · 2008 [cited by applicant]
KR 101038074 · 2011 [cited by applicant]
KR 101101692 · 2011 [cited by applicant]
KR 20110138108 · 2011 [cited by applicant]
KR 20110138572 · 2011 [cited by applicant]
KR 101154858 · 2012 [cited by applicant]
WO WO1991006917A1 · 1991 [cited by applicant]
WO WO1995003569A2 · 1995 [cited by applicant]
WO WO1997025682A1 · 1997 [cited by applicant]
WO WO1998050871A1 · 1998 [cited by applicant]
WO WO2000039737A1 · 2000 [cited by applicant]
WO WO2003098401A2 · 2003 [cited by applicant]
WO WO2007025295A2 · 2007 [cited by applicant]
WO WO2007094772A1 · 2007 [cited by applicant]
WO WO2008092109A2 · 2008 [cited by examiner]
United States Patent and Trademark Office, Final Office Action received for U.S. Appl. No. 17/674,366, dated Dec. 15, 2023, 53 pages, US. [cited by applicant]
United States Patent and Trademark Office, Final Office Action received for U.S. Appl. No. 17/144,426, dated Dec. 19, 2023, 22 pages, US. [cited by applicant]
United States Patent and Trademark Office, Final Office Action received for U.S. Appl. No. 17/158,118, dated Dec. 19, 2023, 22 pages, US. [cited by applicant]
United States Patent and Trademark Office, Non-Final Office Action received for U.S. Appl. No. 16/816,460, dated Dec. 22, 2023, 46 pages, US. [cited by applicant]
United States Patent and Trademark Office, Non-Final Office Action received for U.S. Appl. No. 17/674,366, dated Jun. 5, 2024, 54 pages, US. [cited by applicant]
United States Patent and Trademark Office, Final Office Action received for U.S. Appl. No. 17/162,461, dated Jun. 4, 2024, 38 pages, US. [cited by applicant]
United States Patent and Trademark Office, Non-Final Office Action received for U.S. Appl. No. 16/867,286, dated Mar. 31, 2023, 16 pages, US. [cited by applicant]
United States Patent and Trademark Office, Non-Final Office Action received for U.S. Appl. No. 17/175,939, dated Apr. 26, 2023, 24 pages, US. [cited by applicant]
United States Patent and Trademark Office, Advisory Action received for U.S. Appl. No. 17/144,426, dated Mar. 21, 2024, 5 pages. [cited by applicant]
United States Patent and Trademark Office, Advisory Action received for U.S. Appl. No. 17/674,366, dated Mar. 22, 2024, 6 pages. [cited by applicant]
United States Patent and Trademark Office, Final Office Action received for U.S. Appl. No. 17/705,919, dated Feb. 28, 2024, 61 pages. [cited by applicant]
United States Patent and Trademark Office, Final Office Action received for U.S. Appl. No. 17/175,939, dated Mar. 1, 2024, 24 pages. [cited by applicant]
Pharmacy Reject Codes NCPDP, 5 pages. [cited by applicant]
St. Vincent's first to use Birmingham startup's information system. The Birmingham News [Online] Apr. 11, 2005. URL: http://www.awarix.com. [cited by applicant]
St. Vincent's is Digital Flagship D. Lockridge; Birmingham Medical News [Online] Sep. 2005. [cited by applicant]
Two automatic identification technology, neither new in the sense if being recent developments . . . Patient Safety & Quality Healthcare [Online] August 2005_ URL: http://www_awarix.com. [cited by applicant]
Advisory Action for U.S. Appl. No. 14/193,294 mailed Nov. 9, 2017, 3 pages. [cited by applicant]
Advisory Action for U.S. Appl. No. 15/085,166 dated Apr. 11, 2019, 4 pages. [cited by applicant]
Advisory Action for U.S. Appl. No. 15/085,166 dated Apr. 29, 2020, 3 pages. [cited by applicant]
Advisory Action for U.S. Appl. No. 15/137,371 mailed Feb. 25, 2019, 5 pages. [cited by applicant]
Advisory Action for U.S. Appl. No. 15/427,746 mailed Jul. 2, 2019, 2 pages. [cited by applicant]
Advisory Action received for U.S. Appl. No. 15/085,166, dated Jan. 29, 2021, 3 pages, US. [cited by applicant]
Almaro, Moshe; “Recovery and Reuse of Unused Prescription Drugs” MIT What Matters: Aug. 2005. [cited by applicant]
American Hospital Association, “Drug Price Proposals”, dated Apr. 2019, retrieved from the Internet at <URL: https://www.aha.org/system/files/media/file/2019/04/aha-drug-policy-recommendations_2.pdf>, 8 pages. [cited by applicant]
American Society of Health-System Pharmacists (ASHP), “Is Prescribing the Next Step in the Evolution of Pharmacy?” May 15, 2012. [cited by applicant]
Anonymous, ACS to Demonstrate Electronic Health Record Solution Suite at MMIS 2007 Conference; EHR Tools Consolidate Data, Provide Useful Information at the Point of Care for Medicaid Providers, Payers, and Patients, PR… [cited by applicant]
Anonymous, Medic; On-line Goes In-House, Chain Store Age Executive, Jan. 1987, vol. 63, Issue 1, USA; Abstract only. [cited by applicant]
Anonymous, Pharmacy Industry Leaders Launch Firm to Supply Real-Time Data, PR Newswire, Jul. 30, 2001, p. 1, New York, NY, USA. [cited by applicant]
Anonymous, TechRx Announces Successful Beta Deployment of T-Rex. PR Newswire. May 13, 2002. [cited by applicant]
California Health Care Foundation, “When the Price Is Not Right: State Options on Prescription Drug Pricing”, dated Jun. 2016, retrieved from the Internet at: <URL: https://www.chcf.org/wp-content/uploads/2017/12/PDF-Wh… [cited by applicant]
Cepeda, Maria Soledad, et al., “Quantification of missing prescriptions in commercial claims databases : results of a cohort study.”, Pharmacoepidemiology and Drug Safety, Apr. 2017, pp. 386-392, vol. 26, Epub Jan. 25, … [cited by applicant]
Chu, Kuan-Yu, et al., “Incremental analysis of the reengineering of an outpatient billing process: an empirical study in a public hospital”, BMC Health Services Research, Jun. 13, 2013, vol. 13, No. 215, 8 pages, BioMed… [cited by applicant]
CMS Updates Drug Dashboards with Prescription Drug Pricing and Spending Data, Data, Medicare Part D, Prescription drugs (Mar. 14, 2019). [cited by applicant]
Consalvo, Bob; “City of Boston in the City Council” hearing notice, Dec. 6, 2006. [cited by applicant]
Coping with Information Overload. The News Source for Healthcare Information Technology [Online] Nov. 2004. URL: http://www.awarix.com. [cited by applicant]
Decision to Grant European Patent Application No. 13809457.8 dated May 18, 2017. [cited by applicant]
Dubois, Robert W., “Rx Drug Costs: List Prices Versus Net Prices And The Importance Of Staying Within The Data”, Health Affairs Blog, Mar. 2019, 7 pages. [cited by applicant]
Examiner's Answer for U.S. Appl. No. 14/145,027 mailed Sep. 7, 2016, 27 pages. [cited by applicant]
Extended European Search Report for European Application No. 13809457.8 dated Apr. 15, 2016, 6 pages. [cited by applicant]
Final Office Action for U.S. Appl. No. 12/140,015 mailed Jan. 31, 2011, 10 pages. [cited by applicant]
Final Office Action for U.S. Appl. No. 12/415,062 mailed Oct. 6, 2011, 18 pages. [cited by applicant]
Final Office Action for U.S. Appl. No. 12/555,589 mailed Apr. 11, 2012, 17 pages. [cited by applicant]
Final Office Action for U.S. Appl. No. 12/560,071 mailed Aug. 28, 2015, 8 pages. [cited by applicant]
Final Office Action for U.S. Appl. No. 12/560,071 mailed Nov. 8, 2012, 11 pages. [cited by applicant]
Final Office Action for U.S. Appl. No. 12/570,982 mailed Apr. 11, 2014, 22 pages. [cited by applicant]
Final Office Action for U.S. Appl. No. 12/570,982 mailed Aug. 28, 2015, 10 pages. [cited by applicant]
Final Office Action for U.S. Appl. No. 12/570,982 mailed Jan. 17, 2013, 19 pages. [cited by applicant]
Final Office Action for U.S. Appl. No. 12/730,015 mailed Aug. 14, 2012, 10 pages. [cited by applicant]
Final Office Action for U.S. Appl. No. 12/978,898 mailed May 16, 2013, 16 pages. [cited by applicant]
Final Office Action for U.S. Appl. No. 13/721,890 mailed Jun. 24, 2015, 14 pages. [cited by applicant]
Final Office Action for U.S. Appl. No. 13/721,890 mailed Nov. 25, 2016, 12 pages. [cited by applicant]
Final Office Action for U.S. Appl. No. 13/782,909 mailed May 31, 2016, 18 pages. [cited by applicant]
Final Office Action for U.S. Appl. No. 13/782,909 mailed Oct. 6, 2015, 24 pages. [cited by applicant]
Final Office Action for U.S. Appl. No. 13/804,175 mailed Oct. 6, 2015, 6 pages. [cited by applicant]
Final Office Action for U.S. Appl. No. 13/827,676 mailed Jul. 13, 2015, 17 pages. [cited by applicant]
Final Office Action for U.S. Appl. No. 14/090,113 mailed Jan. 6, 2016, 18 pages. [cited by applicant]
Final Office Action for U.S. Appl. No. 14/090,122 mailed Apr. 22, 2016, 13 pages. [cited by applicant]
Final Office Action for U.S. Appl. No. 14/145,027 mailed Nov. 19, 2015, 12 pages. [cited by applicant]
Final Office Action for U.S. Appl. No. 14/193,294 mailed May 2, 2016, 29 pages. [cited by applicant]
Final Office Action for U.S. Appl. No. 14/218,326 mailed Jun. 30, 2016, 17 pages. [cited by applicant]
Final Office Action for U.S. Appl. No. 15/085,166, dated Dec. 4, 2020, 11 pages. [cited by applicant]
Final Office Action for U.S. Appl. No. 15/137,371 mailed Nov. 28, 2018, 24 pages. [cited by applicant]
Final Office Action for U.S. Appl. No. 15/427,746 mailed Apr. 15, 2019, 9 pages. [cited by applicant]
Google NPL (non-patent literature) Search on “pharmacy payment benefit copay NDC database”, retrieved from the Internet at <https://scholar.google.com/scholar?hl=en&as_sdt=3,47&g=pharmacy+payment+benefit+copay+NDC+datab… [cited by applicant]
Google NPL (non-patent literature) Search on “pharmacy payment benefit copay NDC database”, retrieved from the Internet at <https://www.google.com/search?g =pharmacy+payment+benefit+copay+ndc+database&source=int&tbs=cdr… [cited by applicant]